New Sleep.Ai Study Demonstrates AI's Role In Transforming Preventive Healthcare

(MENAFN- GlobeNewsWire - Nasdaq) Study of 68K Users and 2.7M Nights Validates AI Models for Sleep Apnea and Insomnia; With Further Validation in Progress

CARLSBAD, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Sleep, the company behind the world's most validated sleep intelligence platform, presents results of its machine-learning R&D, demonstrating that smartphone-measured sleep stage data may be used to screen for risk of obstructive sleep apnea and insomnia. The analyses highlight the potential for scalable models to drive major breakthroughs in population health. The conference abstract results will be published in the supplementary issue of Sleep Medicine, the official journal of the World Sleep Society.

Research
The research,“Machine learning-based prediction of sleep apnea and insomnia using objective sleep data from a contactless smartphone application,” was recently presented at the World Sleep Congress in Singapore. Models were trained on 2.7 million nights of objective sleep data from over 68,000 users collected through PSG-validated smartphone app, which uses sonar signals to stage sleep without the need for wearables or external devices.

Results

• Obstructive Sleep Apnea (OSA): model, which used objective sleep data collected from the smartphone app and no questions and answers, exhibited an AUC of 0.80, outperforming some commonly used screening approaches.
• Insomnia: The insomnia model, also using only sleep stage data from the smartphone application, approximated the accuracy of some screening methods with an AUC of 0.73.

Why It Matters
Rates of sleep apnea and insomnia going undiagnosed remain unacceptably high, with nearly 1 billion people globally remaining undiagnosed and untreated due to problems in the entire clinical pipeline, from education and knowledge through to screening, diagnosis, and access to medical and therapeutic services. By adopting smartphone-based screening technologies, Sleep offers a simpler way to enable screening and subsequent treatment.

“Eliminating friction is key to improving population sleep health. These models were deployed on ubiquitous smartphones and may be well-positioned to scale triaging at-risk users for confirmatory testing, potential diagnosis, and timely treatment,” said Elie Gottlieb, PhD, Head of Applied Sleep Science at

Market POV
Most consumer health solutions today rely on wearables, focus narrowly on apnea, or remain limited to early-stage validation. Sleep sets a new benchmark with a smartphone-only, dual-disorder screening model, assessed in real-world conditions, with further clinical validation ongoing. By combining scientific rigor with unmatched scalability, Sleep advances its mission to make research-backed sleep intelligence universally accessible.“We know that people around the world are searching about sleep at a rate higher than any other health topic – we are laser-focused on liberating the data on their phones to drive better sleep health for the purposes of helping them and our partners who serve them,” said Colin Lawlor, CEO at

For more information on this new Sleep study, please visit: .

About Sleep is a leading healthtech company and the world's most advanced sleep intelligence platform, powered by over 840 million hours of proprietary data and more than 250 scientific studies. In 2024, it launched Dein Schlaf , the world's first reimbursed sleep improvement app, through Germany's pioneering preventative health model-sparking interest from major EU insurers.

Founded as SleepScore Labs in 2016 and rebranded in 2025, Sleep offers APIs, SDKs, and a consumer app that enable partners to embed clinically validated, AI-driven sleep technology into their products. Led by Founder and CEO Colin Lawlor and based in Carlsbad, California, the company is backed by investors including Treasure Coast Ventures, Nurture Ventures, and the Harvard Business School Alumni Angels of Greater New York. Learn more at and follow us on LinkedIn .

Media Contact
John McCartney
JMAC PR for

MENAFN25092025004107003653ID1110110620